---
title: "DYMATIC CHEM released its 2024 annual performance, with a net profit attributable to the parent company of 60.9886 million yuan, a year-on-year increase of 101.07%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233622492.md"
description: "DYMATIC CHEM released its 2024 annual report, with operating revenue of 3.056 billion yuan, a year-on-year decrease of 0.69%. The net profit attributable to shareholders was 60.9886 million yuan, a year-on-year increase of 101.07%; the net profit excluding non-recurring gains and losses was 56.076 million yuan, a year-on-year increase of 95.27%. The basic earnings per share were 0.1285 yuan, and it plans to distribute a cash dividend of 0.7 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-28T11:24:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233622492.md)
  - [en](https://longbridge.com/en/news/233622492.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233622492.md)
generator: "portal-rs"
---

# DYMATIC CHEM released its 2024 annual performance, with a net profit attributable to the parent company of 60.9886 million yuan, a year-on-year increase of 101.07%

According to the Zhitong Finance APP, DYMATIC CHEM (002054.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 3.056 billion yuan, a year-on-year decrease of 0.69%. It realized a net profit attributable to shareholders of the listed company of 60.9886 million yuan, a year-on-year increase of 101.07%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 56.076 million yuan, a year-on-year increase of 95.27%. The basic earnings per share were 0.1285 yuan. It plans to distribute a cash dividend of 0.7 yuan (tax included) for every 10 shares to all shareholders

### Related Stocks

- [002054.CN](https://longbridge.com/en/quote/002054.CN.md)

## Related News & Research

- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [MDI: Revenue up 17% year-over-year, with strong pipeline but profit after tax down 3.9%](https://longbridge.com/en/news/296862415.md)
- [BMA: Q2 2026 revenue rose 2% year-over-year, with margins and innovation driving growth](https://longbridge.com/en/news/297275472.md)
- [SPN: Q2 2026 saw record revenue growth, positive EBITDA, and improved margins amid ongoing macro headwinds](https://longbridge.com/en/news/297256815.md)
- [China Risun Group: Net profit jumped 376% on higher margins and new energy growth, with a major battery materials acquisition](https://longbridge.com/en/news/297330227.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**